TheraRadar

Pharma Intelligence, Simplified

Landscape → Respiratory

Allergic Rhinitis

141 clinical trials

33 active
/
141 total (since 2015)
3
Phase 1 Active
25 total
16
Phase 2 Active
49 total
13
Phase 3 Active
53 total
6
Phase 4 Active
27 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 3 0 0
Prime Gene Therapeutics Co., Ltd. 2 0 0
ALK-Abelló A/S 1 3 0
EMS 1 0 3
Keymed Biosciences Co.Ltd 1 2 0
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 1 1 0
Longbio Pharma 1 1 0
Inmunotek S.L. 1 0 1
Eli Lilly 1 0 0
Akeso 1 0 0
AJU Pharm Co., Ltd. 1 0 0
RDC Clinical Pty Ltd 1 0 0
Alixer Nexgen Therapeutics Limited 1 0 0
Daewon Pharmaceutical Co., Ltd. 1 0 0
Guangdong Hengrui Pharmaceutical Co., Ltd 1 0 0
NCT06339008 RECRUITING
A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
Eli Lilly and Company n=450
NCT07060885 RECRUITING
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
ALK-Abelló A/S n=300
NCT07291284 ACTIVE NOT RECRUITING
Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis
Longbio Pharma n=546
NCT07199257 NOT YET RECRUITING
A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis.
Genrix (Shanghai) Biopharmaceutical Co., Ltd. n=144
NCT07168473 RECRUITING
Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma
Daewon Pharmaceutical Co., Ltd. n=274
NCT07154342 RECRUITING
A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis
Genrix (Shanghai) Biopharmaceutical Co., Ltd. n=150
NCT07146126 NOT YET RECRUITING
A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis
Prime Gene Therapeutics Co., Ltd. n=600
NCT06846385 RECRUITING
Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis
Shanghai Mabgeek Biotech.Co.Ltd n=160
NCT06916884 RECRUITING
Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine
Laboratorios Silanes S.A. de C.V. n=70
NCT06061848 RECRUITING
Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT
Lars Olaf Cardell n=360
NCT06608017 NOT YET RECRUITING
Study of Yupingfeng Powder Treating Allergic Rhinitis (AR)
Chinese University of Hong Kong n=140
NCT06272409 NOT YET RECRUITING
Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children.
EMS n=318
NCT05641272 NOT YET RECRUITING
Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract
Inmunotek S.L. n=90
NCT03369704 COMPLETED
Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients
Novartis Pharmaceuticals n=337
NCT05637710 WITHDRAWN
Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil
Eurofarma Laboratorios S.A.
NCT05299086 COMPLETED
As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis
Mahidol University n=68
NCT05692154 COMPLETED
A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis
Opella Healthcare Group SAS, a Sanofi Company n=95
NCT05191186 COMPLETED
Documentation of Efficacy of Intralymphatic Allergen Immunotherapy
Aarhus University Hospital n=450
NCT05214911 COMPLETED
Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in Children
Eurofarma Laboratorios S.A. n=262
NCT05540717 COMPLETED
Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen
Allergy Therapeutics n=555
NCT05093478 COMPLETED
The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis Population
The University of Texas Health Science Center, Houston n=28
NCT05908032 COMPLETED
Study of CM310 in Subjects With Allergic Rhinitis
Keymed Biosciences Co.Ltd n=108
NCT04145219 COMPLETED
House Dust Mite Allergy Trial In Children
ALK-Abelló A/S n=1,460
NCT04981717 TERMINATED
A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat
Regeneron Pharmaceuticals n=446
NCT02320396 COMPLETED
Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)
Organon and Co n=449
NCT04874714 TERMINATED
Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis
Inmunotek S.L. n=18
NCT03654976 COMPLETED
Mite Asthma Pediatric Immunotherapy Trial
ALK-Abelló A/S n=533
NCT04790487 WITHDRAWN
Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis
Larkin Community Hospital
NCT04729517 COMPLETED
Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients
Abdi Ibrahim Ilac San. ve Tic A.S. n=210
NCT05590598 COMPLETED
Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.
Sandoz n=472
NCT05311475 COMPLETED
Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis
Sandoz n=669
NCT04541004 COMPLETED
Adolescent Mite Allergy Safety Evaluation
ALK-Abelló A/S n=253
NCT04709575 COMPLETED
Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis
Regeneron Pharmaceuticals n=353
NCT04670653 WITHDRAWN
Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis
EMS
NCT04637425 COMPLETED
Effect of Bacterial Lysate on Nasal Carriage of Staphylococcus Aureus
Medical University of Lublin n=70
NCT04802616 COMPLETED
The Influence of Nonspecific Immunostimulation on Changes in the Concentration of iNKT Cells
Medical University of Lublin n=80
NCT05276336 COMPLETED
The Effect of Early Radiofrequency Turbinate Reduction on Persistent Allergic Rhinitis
Indonesia University n=32
NCT04264637 COMPLETED
Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis
Bayer n=110
NCT03599791 COMPLETED
DYmista NAsal Spray in CHInese Patients
MEDA Pharma GmbH & Co. KG n=900
NCT04182919 COMPLETED
"Efficacy and Safety of Phlai Capsule Compared to Placebo as the Treatment in Allergic Rhinitis Patients"
Chulalongkorn University n=267
NCT04270552 COMPLETED
Efficacy Of Bacterial Lysate In Children With Allergic Rhinitis
Medical University of Lublin n=76
NCT02953366 WITHDRAWN
Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis
EMS
NCT02953379 WITHDRAWN
Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis
EMS
NCT03755557 COMPLETED
Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray
Marinomed Biotech AG n=82
NCT03990272 COMPLETED
Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua
Beijing Tongren Hospital n=702
NCT04324918 COMPLETED
Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis
Hanmi Pharmaceutical Company Limited n=174
NCT02709538 COMPLETED
Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR)
Glenmark Specialty S.A. n=601
NCT03463031 COMPLETED
Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)
Glenmark Specialty S.A. n=446
NCT03649139 COMPLETED
Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis
Beijing Tongren Hospital n=71
NCT02560948 COMPLETED
Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis
BioTech Tools S.A. n=554
NCT02631551 COMPLETED
Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)
Glenmark Specialty S.A. n=1,180
NCT03655210 COMPLETED
To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients
Hanlim Pharm. Co., Ltd. n=272
NCT02870205 COMPLETED
Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)
Glenmark Specialty S.A. n=1,176

Data: ClinicalTrials.gov